NAM-NK Cells

N/A

Report date: 2024/05/03 20:00:50

Base Information

Drug NameNAM-NK Cells
Drug Alias NameNicotinamide Expanded Haploidentical or Mismatched Related Donor Natural Killer CellsNAM-expanded natural killer cellsNAM-NKGDA-201
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > Natural killer cell therapy
Mechanisms of ActionNatural killer cell replacements
TargetsNot applicable
Therapy Area/IndicationsWaldenstrom MacroglobulinemiaMultiple MyelomaLymphoma, Mantle-Cell +[8] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesGamida Cell Inc
China Registration ClassN/A

Develop Information

Active CompaniesMasonic Cancer Center, University Of Minnesota
Inactive CompaniesGamida Cell Ltd
Active IndicationsWaldenstrom MacroglobulinemiaMultiple MyelomaLymphoma, Mantle-Cell +[8] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A